{"id":746187,"date":"2023-04-10T08:05:27","date_gmt":"2023-04-10T12:05:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/"},"modified":"2023-04-10T08:05:27","modified_gmt":"2023-04-10T12:05:27","slug":"edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/","title":{"rendered":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience"},"content":{"rendered":"
\n

\n Leading <\/em>
\n Center Demonstrates Focal <\/em>
\n HIFU <\/em>
\n as a Tool <\/em>
\n in<\/em>
\n The Management <\/em>
\n of<\/em>
\n Prostate Cancer<\/em>\n <\/p>\n

\n Web<\/em>
\n cast<\/em>
\n scheduled for <\/em>
\n Tuesday, <\/em>
\n April 18<\/em>
\n
\n th <\/em>
\n <\/sup>
\n at 12:00 p.m. PDT<\/em>
\n (3:00 p.m. EDT)<\/em>\n <\/p>\n

LYON, France, April 10, 2023 — EDAP TMS SA (Nasdaq: EDAP) (\u201cthe Company\u201d), a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT).<\/p>\n

The procedure will be performed by Andre Abreu, MD and Amir H. Lebastchi, MD, Assistant Professors of Clinical Urology at Keck Medicine of the University of Southern California (USC).<\/p>\n

\u201cOur team is privileged to work closely with world-class academic medical centers like USC that are leading advances in the care of men with prostate cancer,\u201d said Ryan Rhodes, Chief Executive Officer of EDAP U.S. \u201cWe believe focal therapy is the fastest growing emerging treatment option with the ability to offer excellent oncologic results while maintaining maximum quality of life. Teaching and sharing best practices in new clinical treatments are critical to ensuring more patients can avail themselves of the latest technologies with the absolute best results. We deeply appreciate the patient, physicians, staff and institution sharing this vision of teaching to help other centers adopt this advance with Focal One Robotic HIFU.\u201d<\/p>\n

\u201cUSC Urology\u00a0is committed to developing new modalities that improve patient outcomes when facing prostate cancer,\u201d said Dr. Inderbir Gill,\u00a0urologist with Keck Medicine of USC and\u00a0Chairman and Distinguished Professor of the Catherine and Joseph Aresty Department of Urology at\u00a0Keck School of Medicine of\u00a0USC. \u201cWe were the first\u00a0U.S.\u00a0institution to acquire EDAP\u2019s innovative technology for using non-invasive ultrasound energy to precisely ablate prostate tissue, and we continue to lead in developing this emerging field through clinical research and patient care. We welcome colleagues from around the world to join our team in growing our collective knowledge of the best uses for robotic high intensity focused ultrasound to precisely treat appropriate patients with excellent results.\u201d\u00a0<\/p>\n

For more information and to register for the webinar, please visit www.focalone.com<\/a>.<\/p>\n

\n Andre Luis de Castro Abreu, MD<\/strong> has expertise in MRI\/TRUS fusion prostate biopsy and focal therapy, including High Intensity Focused Ultrasound (HIFU) and Cryoablation, for prostate cancer. He performs \u201cper-lesion\u201d active surveillance for prostate cancer with a detailed 3D mapping of the prostate and cancer location. Dr. Abreu also performs robotic surgery for prostate, kidney and bladder cancers, as well as practicing general urology. During his clinical fellowship at USC, he was involved in more than 400 complex robotic urologic surgeries, treating cancers and benign diseases, and performed more than 1,500 3D prostate biopsies. <\/p>\n

Dr. Abreu has authored many book chapters and more than 85 peer-reviewed publications in various prestigious medical journals. In addition, Dr. Abreu has presented many abstracts on such topics as robotic and laparoscopic urologic surgery, as well as focal therapy, active surveillance and image-guided biopsies. He serves as a reviewer for several journals in the field of urology.<\/p>\n

Dr. Abreu earned his six-year medical degree, in five-year general surgery and urology in Brazil. He then moved to the United States and received his two-year clinical fellowship training at Keck School of Medicine at USC, after being a research scholar for four years at the USC Institute of Urology. <\/p>\n

\n Amir Lebastchi<\/strong>
\n , MD,<\/strong> joined Keck Medicine of USC after completing a residency in urology at the University of Michigan and a fellowship in urological oncology with the National Cancer Institute of the National Institutes of Health. He is dedicated to using the most effective, minimally invasive techniques for urological malignancies. <\/p>\n

Dr. Lebastchi’s research has been published in numerous medical journals, including the New England Journal of Medicine, JAMA Surgery, Nature Reviews Urology and European Urology. He is an invited reviewer for leading medical journals. His goal is to offer patient-centered, compassionate and state-of-the-art care to all his patients.<\/p>\n

Dr. Lebastchi has a special interest in MRI\/TRUS fusion-guided prostate biopsies, a technique that combines magnetic resonance imaging (MRI) and an ultrasound probe. He also specialized in focal therapy for prostate cancer, including noninvasive techniques such as High Intensity Focused Ultrasound (HIFU) and cryoablation. Dr. Lebastchi performs robotic surgery for prostate, kidney and bladder cancer, as well as practicing general urology.<\/p>\n

\n About\u00a0EDAP TMS SA<\/strong>
\n
A recognized leader in the global therapeutic ultrasound market.\u00a0EDAP TMS\u00a0develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various pathologies using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices,\u00a0EDAP TMS\u00a0introduced the Focal One\u00ae in\u00a0Europe\u00a0and in the U.S. as an answer to all requirements for ideal prostate tissue ablation. With the addition of the ExactVu\u2122 Micro-Ultrasound device, EDAP TMS is now the only company offering a complete solution from diagnostics to focal treatment of Prostate Cancer. EDAP TMS also produces and distributes other medical equipment including the Sonolith\u00ae i-move lithotripter and lasers for the treatment of urinary tract stones using extra-corporeal shockwave lithotripsy (ESWL). For more information on the Company, please visit\u00a0http:\/\/www.edap-tms.com<\/a>,\u00a0us.hifu-prostate.com<\/a>\u00a0and\u00a0www.focalone.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

In addition to historical information, this press release contains forward-looking statements within the meaning of applicable federal securities laws, including Section 27A of the U.S. Securities Act of 1933 (the \u201cSecurities Act\u201d) or Section 21E of the U.S. Securities Exchange Act of 1934, which may be identified by words such as \u201cbelieve,\u201d \u201ccan,\u201d \u201ccontemplate,\u201d \u201ccould,\u201d \u201cplan,\u201d \u201cintend,\u201d \u201cis designed to,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cpotential,\u201d \u201cobjective,\u201d \u201ctarget,\u201d \u201cproject,\u201d \u201cpredict,\u201d \u201cforecast,\u201d \u201cambition,\u201d \u201cguideline,\u201d \u201cshould,\u201d \u201cwill,\u201d \u201cestimate,\u201d \u201cexpect\u201d and \u201canticipate,\u201d or the negative of these and similar expressions, which reflect our views about future events and financial performance. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical status and market acceptance of our HIFU devices and the continued market potential for our lithotripsy and distribution divisions, as well as risks associated with the current worldwide inflationary environment, the uncertain worldwide economic, political and financial environment, geopolitical instability, climate change and pandemics like the COVID 19 pandemic, or other public health crises, and their related impact on our business operations, including their impacts across our businesses or demand for our devices and services. <\/p>\n

Other factors that may cause such a difference may also include, but are not limited to, those described in the Company’s filings with the Securities and Exchange Commission and in particular, in the sections “Cautionary Statement on Forward-Looking Information” and “Risk Factors” in the Company’s Annual Report on Form 20-F.<\/p>\n

Forward-looking statements speak only as of the date they are made. Other than required by law, we do not undertake any obligation to update them in light of new information or future developments. These forward-looking statements are based upon information, assumptions and estimates available to us as of the date of this press release, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete.<\/p>\n

\n Company Contact<\/strong>
\n
Blandine Confort
Investor Relations \/ Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
bconfort@edap-tms.com<\/p>\n

\n Investor Contact<\/strong>
\n
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Web cast scheduled for Tuesday, April 18 th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 — EDAP TMS SA (Nasdaq: EDAP) (\u201cthe Company\u201d), a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT). The procedure will be performed by Andre Abreu, MD and Amir H. Lebastchi, MD, Assistant Professors of Clinical Urology … <\/p>\n

Continue reading “EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-746187","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Web cast scheduled for Tuesday, April 18 th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 — EDAP TMS SA (Nasdaq: EDAP) (\u201cthe Company\u201d), a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT). The procedure will be performed by Andre Abreu, MD and Amir H. Lebastchi, MD, Assistant Professors of Clinical Urology … Continue reading "EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-10T12:05:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience\",\"datePublished\":\"2023-04-10T12:05:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/\"},\"wordCount\":1291,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/\",\"name\":\"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==\",\"datePublished\":\"2023-04-10T12:05:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/","og_locale":"en_US","og_type":"article","og_title":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk","og_description":"Leading Center Demonstrates Focal HIFU as a Tool in The Management of Prostate Cancer Web cast scheduled for Tuesday, April 18 th at 12:00 p.m. PDT (3:00 p.m. EDT) LYON, France, April 10, 2023 — EDAP TMS SA (Nasdaq: EDAP) (\u201cthe Company\u201d), a global leader in robotic energy-based therapies, today announced that the Company will host a webcast that will feature a live procedure broadcast of its Focal One HIFU as a potential treatment for ablating cancer tissue in patients who are diagnosed with prostate cancer. The webcast is scheduled for Tuesday, April 18th at 12:00 p.m. PDT (3:00 p.m. EDT). The procedure will be performed by Andre Abreu, MD and Amir H. Lebastchi, MD, Assistant Professors of Clinical Urology … Continue reading \"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/","og_site_name":"Market Newsdesk","article_published_time":"2023-04-10T12:05:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience","datePublished":"2023-04-10T12:05:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/"},"wordCount":1291,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/","name":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==","datePublished":"2023-04-10T12:05:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgwMjg2NSM0MDE1MjI3MjYjMjAyNjkxNQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/edap-announces-live-procedure-broadcast-of-focal-one-high-intensity-focused-ultrasound-hifu-to-global-clinical-audience\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EDAP Announces Live Procedure Broadcast of Focal One High Intensity Focused Ultrasound (HIFU) to Global Clinical Audience"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746187","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=746187"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/746187\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=746187"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=746187"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=746187"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}